Haag SM - Search Results

1

Targeting STING with covalent small-molecule inhibitors.

Haag SM, Gulen MF, Reymond L, Gibelin A, Abrami L, Decout A, Heymann M, van der Goot FG, Turcatti G, Behrendt R, Ablasser A. Haag SM, et al. Nature. 2018 Jul;559(7713):269-273. doi: 10.1038/s41586-018-0287-8. Epub 2018 Jul 4. Nature. 2018. PMID: 29973723

2

Signalling strength determines proapoptotic functions of STING.

Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F, Ablasser A. Gulen MF, et al. Among authors: haag sm. Nat Commun. 2017 Sep 5;8(1):427. doi: 10.1038/s41467-017-00573-w. Nat Commun. 2017. PMID: 28874664 Free PMC article.

3

Murine Monocyte and Macrophage Culture.

Haag SM, Murthy A. Haag SM, et al. Bio Protoc. 2021 Mar 20;11(6):e3928. doi: 10.21769/BioProtoc.3928. eCollection 2021 Mar 20. Bio Protoc. 2021. PMID: 33855110 Free PMC article.

4

Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation.

Guttman O, Le Thomas A, Marsters S, Lawrence DA, Gutgesell L, Zuazo-Gaztelu I, Harnoss JM, Haag SM, Murthy A, Strasser G, Modrusan Z, Wu T, Mellman I, Ashkenazi A. Guttman O, et al. Among authors: haag sm. J Cell Biol. 2022 Jun 6;221(6):e202111068. doi: 10.1083/jcb.202111068. Epub 2022 Apr 21. J Cell Biol. 2022. PMID: 35446348 Free PMC article.

5

Optimized Nonviral Gene Disruption in Primary Murine and Human Myeloid Cells.

Freund EC, Haag SM, Haley B, Murthy A. Freund EC, et al. Among authors: haag sm. Methods Mol Biol. 2023;2618:201-217. doi: 10.1007/978-1-0716-2938-3_15. Methods Mol Biol. 2023. PMID: 36905519

6

Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.

Szardening-Kirchner C, Konrad L, Hauck EW, Haag SM, Eickelberg O, Weidner W. Szardening-Kirchner C, et al. Among authors: haag sm. World J Urol. 2009 Feb;27(1):123-30. doi: 10.1007/s00345-008-0320-x. Epub 2008 Aug 14. World J Urol. 2009. PMID: 18704440

7

Investigation of the antifibrotic effect of IFN-gamma on fibroblasts in a cell culture model of Peyronie's disease.

Haag SM, Hauck EW, Eickelberg O, Szardening-Kirchner C, Diemer T, Weidner W. Haag SM, et al. Eur Urol. 2008 Feb;53(2):425-30. doi: 10.1016/j.eururo.2007.06.036. Epub 2007 Jun 27. Eur Urol. 2008. PMID: 17630104

8

Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease.

Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W, Eickelberg O. Haag SM, et al. Eur Urol. 2007 Jan;51(1):255-61. doi: 10.1016/j.eururo.2006.05.002. Epub 2006 May 19. Eur Urol. 2007. PMID: 16782264

9

[Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Hauck EW, Bschleipfer T, Haag SM, Rohde V, Weidner W. Hauck EW, et al. Among authors: haag sm. Urologe A. 2005 Oct;44(10):1189-92, 1193-6. doi: 10.1007/s00120-005-0867-8. Urologe A. 2005. PMID: 16044283 Clinical Trial. German.

10

Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease.

Hauck EW, Hauptmann A, Haag SM, Bohnert A, Weidner W, Bein G, Hackstein H. Hauck EW, et al. Among authors: haag sm. Eur Urol. 2004 Nov;46(5):623-8; discussion 628. doi: 10.1016/j.eururo.2004.04.028. Eur Urol. 2004. PMID: 15474273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page